Significantly Improved

Related by string. * signifi cantly . SIGNIFICANTLY . significantly : proposal significantly undervalues . Significantly Expands . Significantly Reduces . Significantly Improves . differ significantly / improving . improver . Improving . IMPROVING : Most Improved Player . Improv Theater . improv comedy troupe . Improving Patient Outcomes * Reports Significantly Improved *

Related by context. All words. (Click for frequent words.) 80 Improves Survival 79 Prolongs Survival 79 Significantly Improves 79 Meets Primary Endpoint 78 Fewer Side Effects 78 Improves Outcomes 78 Shows Promising 78 Significantly Reduces 78 Demonstrates Significant 78 Shows Efficacy 78 Drug Candidate 78 Statistically Significant 77 Advanced Melanoma 77 Epilepsy Drug 77 Data Suggest 77 Demonstrated Significant 77 Significantly Reduced 77 Investigational Compound 76 Advanced Colorectal Cancer 76 Rheumatoid Arthritis Patients 76 Showed Significant 76 FDA Approvals 76 Phase IIb Trial 76 Study Demonstrates 76 Gout Drug 76 Demonstrates Positive 76 Significant Improvements 76 Phase 2b Clinical Trial 76 Knee Osteoarthritis 76 Study Evaluating 76 FDA Okays 76 Therapy Improves 76 Previously Treated 76 Improved Survival 76 Anti Tumor 76 Investigational Agent 76 Patients Receiving 76 Clinical Trial Results 76 Lupus Drug 76 Pediatric Patients 76 Significant Improvement 76 Cholesterol Lowering Drug 76 Treated Patients 75 Demonstrates Efficacy 75 Plaque Psoriasis 75 Renal Cell Carcinoma 75 Improve Survival 75 Investigational Drug 75 Single Dose 75 Phase 2a Trial 75 Appears Safe 75 Combination Treatment 75 Osteoporosis Drug 75 Survival Benefit 75 Patients Treated With 75 Adjuvant Treatment 75 Lowers Risk 75 Reduces Risk 75 Low Dose 75 Well Tolerated 75 Phase 2b Trial 75 Capsules CII 75 Antitumor Activity 75 Improves Quality 75 NDA Submission 75 Efficacious 75 Effectively Treats 75 Phase III Clinical Trial 75 Newly Diagnosed Multiple Myeloma 74 Proven Effective 74 Immunomedics Announces 74 Demonstrates Potent 74 Hypertensive Patients 74 Phase 2a Clinical Trial 74 Teva Provides Update 74 Resistant Hypertension 74 Submits NDA 74 Phase IIb Clinical Trial 74 Preclinical Data 74 Present Preclinical Data 74 Demonstrates Statistically Significant 74 Fungal Infections 74 Is Well Tolerated 74 Rheumatoid Arthritis Drug 74 Prostate Cancer Vaccine 74 Initiate Clinical Trial 74 Lung Cancer Survival 74 Lung Cancer Drug 74 Unfractionated Heparin 74 Blood Pressure Drug 74 Obese Patients 74 Prove Effective 74 Anti Tumor Activity 74 Novel Antibiotic 74 Significant Reduction 74 Demonstrates Potential 74 Osteoporosis Drugs 74 Inhaled Corticosteroids 74 Treatment Experienced 74 Shows Promise Against 74 Versus Placebo 74 Treatment Reduces 74 Phase III Trial 74 Adjunctive Therapy 74 Patient Enrollment 74 Schizophrenia Drug 74 Reduced Risk 74 HCV Protease Inhibitor 74 Relapsing Multiple Sclerosis 74 Meta Analysis 74 Prostate Cancer Patients 74 Patients Treated 73 Cholesterol Drug 73 Improve Outcomes 73 Long Term Efficacy 73 Treating Chronic 73 Vildagliptin 73 Effective Than 73 Monotherapy 73 Prolongs Life 73 Orally Active 73 Fracture Risk 73 Myeloma Patients 73 Elderly Patients 73 Antipsychotic Drug 73 Multiple Myeloma Patients 73 Novel Compound 73 Study Showed 73 Shingles Vaccine 73 Shown Effective 73 Study Shows Benefits 73 Novel Mechanism 73 JAK Inhibitor 73 Randomized Trials 73 Arthritis Drug 73 Combo Therapy 73 Nicotine Vaccine 73 Clinical Trial Evaluating 73 Completes Patient Enrollment 73 Kidney Transplant Patients 73 Antitumor 73 Combination Therapy 73 Drug Shows Promise 73 Files IND 73 Trial Evaluating 73 Chronic Hepatitis C 73 Patients Suffering 73 Gene Variant 73 Kidney Function 73 Reduces Pain 73 Testosterone Patch 73 Phase IIa Clinical Trial 73 Advanced Prostate Cancer 73 Migraine Drug 73 Treatment Regimen 73 Study Reinforces 73 Drug Fails 73 Generic Versions 73 Diabetic Patients 73 Impairs 73 Critically Ill Patients 73 Tumor Growth 73 Phase III Trials 73 Hormone Receptor Positive 73 HER2 Positive Breast Cancer 73 Atopic Dermatitis 73 Statin Therapy 73 Prophylactic Treatment 72 FDA Accepts 72 Oral Fingolimod 72 Drug Resistant 72 Proves Effective 72 Novel Oral 72 Demonstrates Sustained 72 Significantly Increases 72 Drug Combo 72 Viral Suppression 72 Novel Therapeutic 72 Predict Risk 72 FDA Clears 72 Presents Preclinical Data 72 Study Casts Doubt 72 Increases Risk 72 Shows Promise 72 Study Evaluates 72 Beta Blocker 72 Levels Linked 72 Osteoarthritis Pain 72 Receives Orphan Drug Designation 72 Anemia Drug 72 Disease Progression 72 Drug Prevents 72 Pulmonary Arterial Hypertension 72 IND Application 72 Osteoporosis Treatment 72 Treatment Resistant 72 Being Studied 72 Aggressive Prostate Cancer 72 Drug Coated Stent 72 Transdermal Patch 72 Investigational Treatment 72 Cholesterol Lowering 72 Controlled Trial 72 Study Shows Significant 72 Mylan Receives Approval 72 Potentially Fatal 72 Panic Disorder 72 Slow Progression 72 Schizophrenia Treatment 72 Prostate Tumors 72 Gene Linked 72 Pivotal Study 72 Helps Relieve 72 Bare Metal Stents 72 Expanded Indication 72 Ischemic Stroke 72 Relapsed Multiple Myeloma 72 Breast Cancer Recurrence 72 Psoriasis Drug 72 Anticancer Activity 72 Testosterone Gel 72 Beneficial Effects 72 Develop Novel 72 Cholesterol Drugs 72 Protease Inhibitor 72 Heart Failure Patients 72 Glucose Control 72 Epilepsy Drugs 72 Tablet Formulation 72 Lung Cancer Patients 72 Inhibits 72 Blood Thinner 72 Generic Version 72 Overactive Bladder 72 Randomized Clinical Trials 72 Bosutinib 72 Asthma Treatment 72 Statin Drugs 72 Phase 2b Study 72 Dose Escalation 72 Rotavirus Vaccine 72 Synthetic Peptide 72 Treatment Naive Patients 71 Sustained Reduction 71 Immune Cells 71 Infected Patients 71 Pooled Analysis 71 Patients Undergoing 71 Postmenopausal Osteoporosis 71 Atypical Antipsychotics 71 Demonstrate Significant 71 Hepatitis C Treatment 71 Mouse Model 71 Genes Predict 71 See CLINICAL PHARMACOLOGY 71 Heartburn Drugs 71 Combination REOLYSIN R 71 Therapeutic Efficacy 71 Initiates Clinical Trial 71 Skeletal Muscle 71 Bone Metastases 71 Adjuvant Therapy 71 Dramatically Increases 71 Metabolic Disorder 71 Diabetic Foot Ulcer 71 Weight Loss Drug 71 Help Detect 71 Study Indicates 71 Fondaparinux 71 Severe Sepsis 71 Genes Linked 71 Clinical Outcome 71 Fixed Dose 71 Inhaled Nitric Oxide 71 Non Responders 71 Chronic Hepatitis B 71 Prostate Surgery 71 Study Proves 71 Artery Disease 71 Enlarged Prostate 71 Renal Impairment 71 Pre Cancerous 71 Adverse Effects 71 Therapeutic Potential 71 Vaginal Gel 71 Treatment Naïve 71 Liver Failure 71 Initiates Clinical Trials 71 Lowers Blood Pressure 71 Clinical Efficacy 71 Drug Coated Stents 71 Sleep Disturbances 71 Sustained Efficacy 71 Obese Teens 71 Relapsed Refractory 71 Peginterferon 71 FDA Panel Recommends 71 Hormonal Therapy 71 Menopausal Women 71 Prevent Stroke 71 Immunosuppressant 71 Relapsing Remitting Multiple Sclerosis 71 Boosts Survival 71 Disease Modifying 71 Completes Enrollment 71 Gastric Cancer 71 Premenopausal Women 71 Treatment Shows Promise 71 Mg Usa 71 Hemodialysis Patients 71 Strongly Linked 71 Virus Infection 71 Osteoarthritis Patients 71 Node Positive 71 Hormone Refractory Prostate Cancer 71 Gene Variation 71 Significantly Improve 71 Dramatically Reduce 71 Symptom Relief 71 Presents Positive 71 Migraine Headaches 71 Vaccine Adjuvant 71 First Patient Treated 71 Granted Orphan Drug 71 Benign Prostatic Hyperplasia 71 Technological Advances 71 Can Predict 71 Dramatically Reduced 71 Tyrosine Kinase Inhibitor 71 Hematological Cancers 71 Adjuvant Chemotherapy 71 Inhaled Insulin 71 Receives Approvable Letter 71 FDA Warns Against 71 Non Inferiority 71 Gene Variants 71 Urine Test 71 Localized Prostate Cancer 71 Antiviral Drugs 70 Long Term Outcomes 70 Long Term Survival 70 BioElectronics Announces 70 Treating Depression 70 ADHD Medication 70 Seasonal Influenza Vaccine 70 Secondary Hyperparathyroidism 70 Lower Blood Pressure 70 Anti Clotting Drug 70 Substantially Reduce 70 Refractory Hodgkin Lymphoma 70 Guidelines Issued 70 Cocaine Addiction 70 FDA Approves Drug 70 Preclinical Study 70 Estrogen Therapy 70 Nebulized 70 Helps Predict 70 Study Compares 70 Oral Calcitonin 70 Hepatitis C Genotype 70 Preterm Labor 70 First Patient Enrolled 70 Device Helps 70 Less Invasive 70 Premature Infants 70 Non Invasive Treatment 70 Carotid Stenting 70 Smallpox Vaccine 70 Extended Release 70 Tumor Cell 70 Treating Heart Failure 70 Slows Progression 70 Dose Response 70 Test Detects 70 Successfully Completed 70 Diabetic Kidney Disease 70 Protein Linked 70 Phase IIa Trial 70 Holds Promise 70 Anemia Drugs 70 Inflammatory Markers 70 Contrast Agent 70 Announce Collaboration Agreement 70 Insulin Glargine 70 Migraine Treatment 70 Initiates Phase III 70 Positive Opinion 70 Pain Relievers 70 Therapy Reduces 70 Sustained Release 70 Minimally Invasive Treatment 70 Recombinant Human 70 Antipsychotic 70 Desvenlafaxine Succinate 70 Previously Untreated 70 Chronic Cough 70 Brain Metastases 70 Elevated Levels 70 Stent Restenosis 70 II Clinical Trial 70 Topical Treatment 70 Lupus Nephritis 70 Antibiotic Resistant 70 Antipsychotic Drugs 70 Invasive Fungal Infections 70 Immune Responses 70 Initiates Clinical 70 Renal Cancer 70 Antifungal 70 Brain Scans 70 Phase 1b Clinical Trial 70 Laryngeal Cancer 70 Inflammatory Arthritis 70 Certain Cancers 70 Chemotherapy Regimen 70 Tipranavir 70 Announces FDA Clearance 70 Genetic Mutation 70 Confirmatory Phase 70 Further Validates 70 VIVUS Announces 70 Effective Treatments 70 Complicated Skin 70 Leukemia Cells 70 Achieves Positive 70 Male Contraceptive 70 Obesity Linked 70 Ebola Vaccine 70 Stronger Warnings 70 Initiate Phase III 70 Novel Inhibitor 70 Chronic Sinusitis 70 Eszopiclone 70 Tumor Cells 70 Proves Successful 70 Castration Resistant Prostate Cancer 70 Commonly Used 70 Hormone Therapy 70 Kinase Inhibitor 70 Anticancer Drugs 69 Develops Novel 69 Significant Increase 69 Often Misdiagnosed 69 Antidepressant Drug 69 Subgroup Analysis 69 Anti Inflammatory 69 Predict Prostate Cancer 69 Detect Cancer 69 Third Consecutive Quarter 69 Hypercholesterolemia 69 Tiotropium 69 Interferon Alpha 69 Statistical Significance 69 Initiates Enrollment 69 Hsp# Inhibitor 69 Shows Statistically Significant 69 Oral Formulation 69 Stem Cell Treatment 69 Pivotal Phase III 69 Polymerase Inhibitor 69 Calcium Supplements 69 Increased Risk 69 Prostate Biopsy 69 Eases Pain 69 Therapeutic Antibody 69 Nucleoside 69 Pain Medications 69 Clinically Tested 69 Metastatic Colorectal Cancer 69 Antibiotic Use 69 Helps Prevent 69 Blood Pressure Drugs 69 Stable Angina 69 Metastatic Renal Cell Carcinoma 69 Initiates Dosing 69 Attenuates 69 Allergic Reactions 69 Antidepressants Linked 69 Autologous Stem Cell Transplantation 69 Prognostic Value 69 Anti Inflammatory Drug 69 SPRYCEL ® 69 Widely Used 69 Demonstrates Superior 69 Double Blind Randomized 69 Magnetic Stimulation 69 Venous Thromboembolism 69 Painkiller Abuse 69 Commonly Prescribed 69 Interferon Beta 69 Fast Track Status 69 Induces 69 Could Prevent 69 Increased Mortality 69 Severe Asthma 69 Efficacy Trial 69 Diagnostic Criteria 69 Colorectal Cancer Risk 69 Renal Function 69 Cause Weight Gain 69 Neoadjuvant Chemotherapy 69 Breast Cancer Cells 69 Postmenopausal Women 69 Contrast Agents 69 Flamel Technologies Announces 69 IND Filing 69 Calcium Vitamin D 69 Confirms Efficacy 69 Severe Acne 69 RNAi Therapeutic 69 Study Concludes 69 Cardiogenic Shock 69 Mitigates 69 Coronary Arteries 69 Ovarian Cancer Patients 69 Pharmacokinetic Study 69 Cyclooxygenase 2 69 Milestone Payment 69 Improve Quality 69 Pneumonia Vaccine 69 Orthostatic Hypotension 69 Advanced Ovarian Cancer 69 Suppresses 69 Gene Mutation 69 Sirolimus Eluting Stent 69 Correlation Between 69 Anticancer Drug 69 Randomized Double Blind 69 Treatment Naive 69 Genetic Tests 69 Endometrial Cancer 69 More Than Doubled 69 Acne Drug 69 Allergic Rhinitis 69 Cancer Recurrence 69 Brain Cells 69 Files Patent Application 69 FDA APPROVES 69 Potent Antiviral Activity 69 Metastatic Prostate Cancer 69 Cardiovascular Events 69 Abdominal Pain 69 Radical Prostatectomy 69 Partial Onset Seizures 69 Ovarian Cancer Treatment 69 Colorectal Cancer Patients 69 Cholesterol Levels 69 Results Confirm 69 Vaccine Candidate 69 Blood Clot Risk 69 Lung Cancer Trial 69 Psoriasis Patients 69 Muscle Wasting 69 Double Blind Placebo 69 Randomized Controlled Trials 69 Genetic Defect 69 Intravenous Formulation 69 JAK2 Inhibitor 69 Proton Pump Inhibitors 69 Poorly Controlled 69 Erectile Dysfunction Drug 69 Lanthanum Carbonate 69 Peginterferon Alfa 2a 69 Bone Mineral Density 69 Glatiramer Acetate 69 Chemotherapy Improves 69 Breast Cancer Stem Cells 69 Univest Corporation Declares 69 Bipolar Depression 69 Antiangiogenic 69 Bone Fracture 69 Improve Patient 69 Menopausal Symptoms 69 Clinical Trial Data 69 TNF Blockers 68 Left Ventricular Hypertrophy 68 Study Confirms 68 Fibromyalgia Pain 68 Carboplatin Paclitaxel 68 Autoimmune Disorders 68 Could Save Lives 68 RNAi Therapeutics 68 Liver Transplant Patients 68 Could Predict 68 Total Knee Arthroplasty 68 Receives Positive 68 Viral Load 68 Pegylated 68 Septic Shock 68 Chemoradiation 68 Successfully Treated 68 Hemoglobin Levels 68 Weight Loss Supplement 68 Adversely Affect 68 Cognitive Impairment 68 Dendritic Cells 68 Significantly Reduce 68 Hepatic Encephalopathy 68 Plus Ribavirin 68 Chronic Renal Failure 68 Protease Inhibitors 68 Glycemic Control 68 Acute Pancreatitis 68 Acute Heart Failure 68 Cites Positive 68 Antidepressant Use 68 Injectable Drug 68 ACE Inhibitors 68 Treat Heart Failure 68 Treatment Naive HIV 68 Stem Cell Transplants 68 Higher Doses 68 Epoetin Alfa 68 Meet Primary Endpoint 68 Helps Identify 68 Spinal Fusion 68 Inhaled Steroids 68 Cypher Sirolimus 68 Negative Effects 68 Advanced Pancreatic Cancer 68 Adenoma 68 ORLive Presents 68 Prognostic Factors 68 Pregnancy Linked 68 Anti Nausea 68 Sequential Growth 68 Breast Cancer Treatment 68 Diabetic Nephropathy 68 Successfully Completes Phase 68 Receives Positive Opinion 68 Anticoagulant 68 Key Milestones 68 Randomized Double blind 68 Insulin Resistance 68 Gene Mutations 68 Prolongs 68 Monoclonal Antibody 68 Receives Milestone Payment 68 Vitamin D Linked 68 Bipolar Mania 68 Genetic Variant 68 Boosts Productivity 68 Trial Halted 68 Remains Flat 68 Paclitaxel Carboplatin 68 Systemic Delivery 68 Liver Toxicity 68 Pivotal Phase 68 Spectrum Pharmaceuticals Announces 68 Moderate Drinking 68 Liver Damage 68 Significant Reductions 68 Stent Placement 68 Revised Upward 68 Insulin Sensitivity 68 Oral Laquinimod 68 Help Smokers Quit 68 AnaSpec Introduces 68 Begins Shipment 68 Controlled Study 68 Medoxomil 68 Myelodysplastic Syndromes 68 Stomach Cancer 68 Mimetics 68 Predict Response 68 Cervical Dysplasia 68 Achieves Milestone 68 Cinacalcet 68 Clinical Study Shows 68 Protein Involved 68 Heart Stents 68 Collaborators Present 68 Respiratory Virus 68 Abortion Pill 68 Metastatic Melanoma 68 Preterm Delivery 68 Breast Tumors 68 Maleate 68 Visceral Fat 68 NICE Recommends 68 Diagnostic Tests 68 Newly Identified 68 Amplifies 68 Accelerate Commercialization 68 Cognitive Function 68 Transdermal Delivery 68 Ample Supply 68 Prognostic Significance 68 Placebo Controlled Study 68 Widely Available 68 Antiviral Activity 68 Diet Pill 68 Cancer Cells 68 Kidney Transplants 68 Cancer Treatments 68 Prospective Randomized 68 Urinary Incontinence 68 Begin Clinical Trials 68 Viable Alternative 68 ANADIGICS Announces 68 Hepatitis C Patients 68 Various Types 68 Cervical Cancer Vaccine 68 Multicenter Trial 68 Clinically Proven 68 Receives Orphan Drug 68 Iron Deficiency 68 Sirolimus Eluting 68 Prevent Prostate Cancer 68 Platelet Inhibition 68 Generalized Anxiety Disorder 68 Post Menopausal 68 Placebo Controlled Trial 68 Virus Linked 68 Treatment Naïve Patients 68 Initiates Phase II 68 Blood Pressure Lowering 68 Malignant Glioma 68 Patent Covering 68 Antiplatelet 68 Fatty Foods 68 Oral Anticoagulant 68 Cardiovascular Disease Risk 68 Transplant Patients 68 Tremendous Growth 68 Immune Cell 68 Genes Associated 68 Postherpetic Neuralgia 68 Acute Coronary Syndromes 68 PPD Declares 68 Therapy Shows Promise 68 Radiation Induced 68 Sex Hormones 68 Hip Fractures 68 Japanese Stocks Climb 68 Novel Protein 68 Weight Loss Pill 68 XPEL Announces 68 Potentially Harmful 68 Treat Anemia 67 Subtypes 67 Study Validates 67 Mg Uk 67 Emerging Therapies 67 Epithelial Cell 67 Anticancer Agent 67 Experimental Vaccine 67 Randomized Placebo Controlled Trial 67 Doctors Warn 67 Pivotal Trials 67 Healthbeat Report 67 Skin Lesions 67 Electrical Stimulation 67 Achieves Primary Endpoint 67 Hospitalized Patients 67 Potent Anti 67 Antioxidant Supplements 67 Blood Vessels 67 Lipid Levels 67 Lowers Cholesterol 67 Improved Outcomes 67 Primary Endpoint 67 Home Hemodialysis 67 Smooth Muscle 67 FDA Approves 67 Darbepoetin Alfa 67 Phase III Pivotal Trial 67 Provides Detailed 67 Hepatitis B Vaccine 67 Helps Smokers Quit 67 Kidney Failure 67 Hospital Acquired Pneumonia 67 Silicone Breast Implants 67 Telik Announces 67 Advanced Renal Cell 67 Drug Resistant Tuberculosis 67 Nerve Regeneration 67 Helps Ease 67 Genetically Engineered Salmon 67 Gastrointestinal Disorders 67 Abdominal Fat 67 Initiates Phase 2b 67 STERIS Corporation Announces 67 Epoetin 67 Chronic Inflammation 67 Parathyroid Hormone 67 Anthrax Toxin 67 Excessive Sweating 67 Anthracycline 67 Immunotherapeutic 67 Phospholipase A2 67 Larger Than Expected 67 Demonstrates Improved 67 Data Indicate 67 Reduce Risk 67 Announces Initiation 67 Reduces Mortality 67 Nearly Doubled 67 Clinical Evaluation 67 Osteoarthritis Knee Pain 67 Humanized Anti 67 Capecitabine 67 Drug Makers 67 Files Investigational 67 Vaccine Shows Promise 67 Newly Diagnosed 67 Provides Guidance 67 Investigational Oral 67 Smoking Linked 67 Vitamin Supplements 67 PRN FDA Approves 67 Study Analyzes 67 Bacterial Infection 67 Long Lasting 67 ISTODAX ® 67 Posaconazole 67 Thyroid Hormone 67 Prevent Heart 67 Diuretic 67 Improves Accuracy 67 Release Tablets 67 Unresectable 67 Results Indicate 67 Help Predict 67 Lung Cancer Risk 67 STELARA TM 67 Vaccine Protects Against 67 Predict Dementia 67 Zoledronic Acid 67 Treatment Outcome 67 Receives FDA Clearance 67 Tumor Targeting 67 Pneumococcal Vaccine 67 Genetic Disorder 67 Hematological Malignancies 67 Breast Density 67 Panel Advises 67 Metastatic Pancreatic Cancer 67 Growth Slowing 67 Liver Injury 67 Unapproved Drugs 67 Genes Involved 67 Reveals Positive 67 Avian Flu Vaccine 67 Bronchodilator 67 Shows Modest 67 Reveals Significant 67 NMDA Receptor 67 Asthma Medication 67 Receives Patent 67 Gets FDA Clearance 67 Radiation Dose 67 Fulvestrant 67 Prenatal Exposure 67 Breast Tumor 67 Launches Generic Version 67 Diabetic Neuropathy 67 FDA Clearance 67 Useful Tool 67 Drug Eluting 67 Ziprasidone 67 Percutaneous Tibial Nerve Stimulation 67 Differentiates 67 Sees Steady 67 TB Vaccine 67 Acute Migraine 67 Improve Profitability 67 Neuroprotective Effects 67 Acute Ischemic Stroke 67 Serious Infections 67 Injection Site 67 FDA Cracks Down 67 Thyroid Function 67 Gastric Ulcers 67 Breast Cancer Patients 67 Breast Cancers 67 ST Elevation Myocardial 67 Kaydon Corporation Announces 67 Dose Finding 67 Summarizes 67 Antibiotic Treatment 67 Novel Compounds 67 Serious Side Effects 67 Melphalan 67 Sexual Satisfaction 67 Extended Release Formulation 67 Stent Implantation 67 Strengthens Balance Sheet 67 Rat Poison Found 67 Protein Synthesis 67 Brain Atrophy 67 Diamyd Medical Diamyd 67 Functional Outcomes 67 HER2 Positive 67 Carotid Artery Stenting 67 Reports Positive 67 Sinus Infections 67 Pose Serious 67 Asthma Symptoms 67 Hyperlipidemia 67 Lipid Lowering 67 Predict Breast Cancer 67 Primary Hypercholesterolemia 67 Begins Dosing 67 Bone Marrow Cells 67 EntreMed Presents 67 Steep Rise 67 Clinically Significant 67 Modulates 67 Initiate Phase 67 Naive Patients 67 Telithromycin 67 Pharmacologic Treatment 67 Cell Proliferation 67 Telaprevir VX 67 Regimens 67 Antigen Specific 67 Cardiotoxicity 67 Prostate Cancer Treatment 67 Post Operative 67 Patients Enrolled 67 Be Cured 67 Demonstrates Long Term 67 Cyclophosphamide 67 Suicidality 67 Drug Maker 67 Imaging Technique 67 Pending Acquisition 67 Cancer Stem Cells 67 Blood Flow 67 Cautious Optimism 67 Left Ventricular 67 Small Molecule 67 Therapeutic Vaccine 67 Authorized Generic 67 Signaling Pathway 67 FDA Approves Generic 67 Chronic Insomnia 67 GRAS Status 67 Reconfirms 67 Patient Outcomes 67 Bisphosphonate 67 Phase Ib Clinical Trial 67 Helps Reduce 67 Study Examines 67 Partial Nephrectomy 67 Crit Rev 67 Reduces Cost 67 Deep Venous Thrombosis 67 Cognitive Decline 67 Chronic Constipation 67 Survival Rates 67 ER Visits 67 Reduce Mortality 67 Atypical Antipsychotic 67 Brain Tumor Patients 67 Adefovir 67 Reduce Unnecessary 67 Hormone Levels 67 Less Than Half 67 Physical Function 67 Molecular Mechanism 67 Achieve Breakthrough 67 Radiofrequency Ablation 67 Generic Version Of 67 Settle Patent Litigation 66 Taro Receives 66 Signaling Pathways 66 Tissue Engineered 66 Contrast Enhanced 66 Resubmission 66 Study Identifies 66 Dose Ranging 66 Artificial Cornea 66 Asthma Attacks 66 Renal Insufficiency 66 Bird Flu Vaccine 66 Detect Breast Cancer 66 Drug Combinations 66 Anti CD# Antibody 66 Blocked Arteries 66 Opioid Addiction 66 Tolerability 66 Generic Protonix 66 Reacquires 66 Bivalirudin 66 Impotence Drug 66 VIVITROL ® 66 Multiplies 66 Antidepressant Treatment 66 Pharmacyclics Announces 66 Chemotherapy Induced 66 Recommends Approval 66 Cardiovascular Outcomes 66 Tuberculosis Vaccine 66 Beta Blockers 66 Pivotal Clinical Trial 66 Hepatitis C Virus 66 CorVel Announces

Back to home page